Compositions And Methods For Reducing Food Cravings
AssigneeNalpropion Pharmaceuticals LLC
InventorsAnthony A. McKinney, Gary D. Tollefson, Michael Alexander Cowley
Life of this patent
Estimating the term…
Abstract
Disclosed are compositions for reducing food cravings, comprising a first compound and a second compound, where the first compound is an opioid antagonist and the second compound is an α-MSH agonist. Also disclosed are methods of reducing food cravings, comprising identifying an individual in need thereof and treating that individual to antagonize opioid receptor activity and to enhance α-MSH activity.
Claims18
1-34. (canceled)
A method of reducing food cravings in a patient suffering therefrom comprising administering a daily dose of naltrexone or a pharmaceutically acceptable salt thereof and bupropion or a pharmaceutically acceptable salt thereof to the patient for a period of at least 4 weeks in an amount that is effective to reduce a food craving.
Dependencies are inferred from the claim text.